Condition
Premenopausal
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownGonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During ChemotherapyNCT07127315 · 2022-06-01
COMPLETEDComprehensive Lifestyle Change To Prevent Breast CancerNCT03448003 · 2019-04-04
ACTIVE_NOT_RECRUITINGStress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerNCT03505736 · 2018-06-21
COMPLETEDSurgery in Preventing Ovarian Cancer in Patients With Genetic MutationsNCT02760849 · 2016-05-02
ACTIVE_NOT_RECRUITINGEverolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsNCT02152943 · 2014-07-17
COMPLETEDCommon interventions
Laboratory Biomarker AnalysisOTHER2AdenosineBIOLOGICAL1Cancer PreventionOTHER1ChemotherapyDRUG1EverolimusDRUG1Gonadotropin-releasing hormone agonistDRUG1LetrozoleDRUG1Magnetic Resonance ImagingPROCEDURE1OophorectomyPROCEDURE1Quality-of-Life AssessmentOTHER1Questionnaire AdministrationOTHER1RegadenosonDRUG1SalpingectomyPROCEDURE1Salpingo-OophorectomyPROCEDURE1Stress Management TherapyPROCEDURE1TrastuzumabBIOLOGICAL1
Leading sponsors
Trial status mix
COMPLETED3
ACTIVE_NOT_RECRUITING2
Phase mix
NA3
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.